Latest News and Press Releases
Want to stay updated on the latest news?
-
TORONTO, July 09, 2019 (GLOBE NEWSWIRE) -- With Richmond Hill Council set to consider proposed amendments to their sign by-law to allow for the use of real estate open house signs on public...
-
NEW YORK, July 09, 2019 (GLOBE NEWSWIRE) -- Synthesio, the company behind the leading global Social Media Intelligence Suite, is excited to announce the release of Signals, a state-of-the-art trend...
-
NEW YORK, July 09, 2019 (GLOBE NEWSWIRE) -- Synthesio, das Unternehmen hinter der weltweit führenden Social Media Intelligence Suite, freut sich, die Veröffentlichung von Signals bekannt zu geben,...
-
NEW YORK, 09 juill. 2019 (GLOBE NEWSWIRE) -- Synthesio, un des leaders mondiaux en solutions de social media intelligence, a le plaisir d'annoncer la sortie de Signals, un nouveau module d’analyse...
-
ลอนดอน, July 08, 2019 (GLOBE NEWSWIRE) -- ในวันนี้ International Association for the Study of Lung Cancer (IASLC), Guardant Health,Global Lung Cancer Coalition (GLCC) และ AstraZeneca ร่วมกันเปิดตัว...
-
런던, July 09, 2019 (GLOBE NEWSWIRE) -- 국제폐암연구협회(IASLC), 가던트헬스(Guardant Health), 국제폐암연맹(GLCC), 그리고 아스트라제네카가 주요 사망 원인인 폐암의 치명성을 극복하기 위한 새로운 파트너십인 Lung Ambition Alliance를 발족했다. 본 단체의 첫 목표는 2025년까지 폐암 환자...
-
ロンドン発 , July 09, 2019 (GLOBE NEWSWIRE) -- 国際肺癌学会 (International Association for the Study of Lung Cancer、IASLC)、ガーダントヘルス (Guardant Health)、国際肺癌連盟 (Global Lung Cancer Coalition、GLCC)、アストラゼネカ...
-
LONDON, July 08, 2019 (GLOBE NEWSWIRE) -- Die International Association for the Study of Lung Cancer (IASLC), Guardant Health, die Global Lung Cancer Coalition (GLCC) und AstraZeneca gaben heute die...
-
LONDRES, 08 juill. 2019 (GLOBE NEWSWIRE) -- Aujourd'hui, l'International Association for the Study of Lung Cancer (IASLC ou Association internationale pour l'étude du cancer du poumon), Guardant...
-
伦敦, July 08, 2019 (GLOBE NEWSWIRE) -- 今天,国际肺癌研究协会(IASLC)、Guardant Health、全球肺癌联盟(GLCC)和AstraZeneca宣布建立“肺健康目标联盟(Lung Ambition Alliance)”,这是以消除肺癌死亡率为目标的一项雄心勃勃的新的合作伙伴关系。该联盟的第一个目标是到2025年将肺癌患者的五年生存率提高一倍。 ...